Favorable existing soil, plant and weather data paired with nutrient density testing will aid community health outcomes
FDA Submission Timeline Based on the TRIUMPH-4 success and expected 2026 readouts, analysts predict: Late 2026: Completion of core TRIUMPH trials Q4 2026 or Q1 2027: New Drug Application (NDA) submission to FDA Mid to Late 2027: Potential FDA approval Early 2028: Commercial launch Eli Lilly has not officially confirmed these timelines, but the company has indicated it will submit for regulatory approval once sufficient Phase 3 data is available
There has been varying signals in the literature to date, but it seems like for many people taking it anywhere from 10-50% of the weight lost is muscle weight
More recently, these agents have gained popularity in assisting in weight loss
And I think what's happening, interestingly, is a new norm is occurring where they're starting to get hungry again, but they're not overeating
The timeline for seeing results from GLP-1 medications varies depending on the specific outcome being measured and the individual patient
